Research Inhaled cannabis could treat ocular hypertension, glaucoma: study The results show that smoking pot can produce up to a 16% reduction in eye pressure Nick LabaFebruary 11, 2022
Business Flat sales, $75M net loss for Aurora in Q2 With adult-use sales halved from a year ago, the large majority of the firm's sales now come from international medical markets Nick LabaFebruary 10, 2022
Business Neptune reports Q3 revenue up 17% to $18.4M, net loss of $21M Taking a recent majority stake in a baby food maker, Neptune joins other pot firms expanding broadly into different CPG categories Nick LabaFebruary 10, 2022
Business Canopy’s recreational pot sales drop 18% in Q3 But sales for the firm's BioSteel sports drinks and Storz & Bickel vaporizers have been rising Nick LabaFebruary 9, 2022
Business Israel-based InterCure previews record sales of $31M The firm says it commands 30% of the country's medical cannabis market Nick LabaFebruary 8, 2022
Business Ontario sets clearer rules against pay-to-play retail deals The updated rules also ban house brands and in-store advertising Nick LabaFebruary 8, 2022
Policy Pennsylvania starts process to consider legalizing adult-use cannabis A first hearing, focused primarily on issues related to enforcement, was held Monday Nick LabaFebruary 7, 2022
Business Auxly shutters 2 Nova Scotia facilities The firm says the move will have no material impact on its cultivation or processing capabilities Nick LabaFebruary 7, 2022
News Oregon cannabis operators lobby to reinstate lid on new licences Industry advocates say the moratorium protects local businesses while allowing larger firms to thrive Nick LabaFebruary 4, 2022
Business Nextleaf ups annual sales to $3.4M but cash reserves run low In December, the firm finished a public offering for proceeds of $3.2 million Nick LabaFebruary 3, 2022